Boon or Bane? Anti-Tumor Necrosis Factor Therapy Complicated by Listeria monocytogenes Meningitis Culminating in Colectomy for Ulcerative Colitis

Anti-tumor necrosis factor (TNF) biologics have revolutionized the management of inflammatory bowel diseases (IBDs) by promoting mucosal healing and delaying surgical intervention in ulcerative colitis (UC). However, biologics can potentiate the risk of opportunistic infections alongside the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagpal, Ria, Ulaganathan, Hemnaath, Khan, Khushal, Egan, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251708/
https://www.ncbi.nlm.nih.gov/pubmed/37303967
http://dx.doi.org/10.14740/jmc4041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251708/
https://www.ncbi.nlm.nih.gov/pubmed/37303967
http://dx.doi.org/10.14740/jmc4041

Ejemplares similares